Ignite Creation Date:
2025-12-24 @ 1:09 PM
Ignite Modification Date:
2026-02-25 @ 7:08 PM
Study NCT ID:
NCT03339661
Status:
COMPLETED
Last Update Posted:
2021-06-07
First Post:
2017-11-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Secondary Prophylaxis After CMV Disease in Kidney Transplant Patients Targeted by γδ T Cells Immunomonitoring.
Sponsor:
University Hospital, Bordeaux
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CHUBX 2016/40
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None